Literature DB >> 2182305

Intrabronchial selective coagulative treatment of hemoptysis. Report of three cases.

L Bense1.   

Abstract

In three patients with hemoptysis, fibrin precursors were sprayed into the bronchus selectively to the site of the bleeding. In this way, four hemoptyses, resistant to other therapy, were arrested without any adverse effect. The total loss of blood was estimated at least 9 L, and it was substituted by transfusion of more than 8 L. The new method is described and its possible modes of action are discussed. This selective intrabronchial local coagulative method may be the proper symptomatic treatment of choice if causal therapy is ineffective or not available for any reason.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182305     DOI: 10.1378/chest.97.4.990

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Novel Bronchoscopic Management of Airway Bleeding With Absorbable Gelatin and Thrombin Slurry.

Authors:  A Rolando Peralta; Mohit Chawla; Robert P Lee
Journal:  J Bronchology Interv Pulmonol       Date:  2018-07

Review 2.  Approach to Hemoptysis in the Modern Era.

Authors:  Sébastien Gagnon; Nicholas Quigley; Hervé Dutau; Antoine Delage; Marc Fortin
Journal:  Can Respir J       Date:  2017-12-21       Impact factor: 2.409

3.  Use of intrapulmonary administration of thrombin in hematological malignancy patients with alveolar haemorrhage: A case series.

Authors:  Jongmin Lee; Chin Kook Rhee; Seok Chan Kim; Young Kyoon Kim; Hee Je Kim; Seok Lee; Seok-Goo Cho; Jong Wook Lee
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

4.  Management of recurrent haemoptysis in malignancy with combined TISSEEL and intrabronchial valves.

Authors:  James Di Michiel; Corinna Pan; Alvin Ing; Tajalli Saghaie
Journal:  Respirol Case Rep       Date:  2019-01-31

Review 5.  Bronchoscopy in the intensive care unit.

Authors:  P Jolliet; J C Chevrolet
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.